Cargando…
Identification of an Effective Early Signaling Signature during Neo-Vasculogenesis In Vivo by Ex Vivo Proteomic Profiling
Therapeutic neo-vasculogenesis in vivo can be achieved by the co-transplantation of human endothelial colony-forming progenitor cells (ECFCs) with mesenchymal stem/progenitor cells (MSPCs). The underlying mechanism is not completely understood thus hampering the development of novel stem cell therap...
Autores principales: | Rohban, Rokhsareh, Reinisch, Andreas, Etchart, Nathalie, Schallmoser, Katharina, Hofmann, Nicole A., Szoke, Krisztina, Brinchmann, Jan E., Rad, Ehsan Bonyadi, Rohde, Eva, Strunk, Dirk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691264/ https://www.ncbi.nlm.nih.gov/pubmed/23826172 http://dx.doi.org/10.1371/journal.pone.0066909 |
Ejemplares similares
-
Oxygen Sensing Mesenchymal Progenitors Promote Neo-Vasculogenesis in a Humanized Mouse Model In Vivo
por: Hofmann, Nicole A., et al.
Publicado: (2012) -
Renal Subcapsular Transplantation of PSC-Derived Kidney Organoids Induces Neo-vasculogenesis and Significant Glomerular and Tubular Maturation In Vivo
por: van den Berg, Cathelijne W., et al.
Publicado: (2018) -
Heparin and Derivatives for Advanced Cell Therapies
por: Laner-Plamberger, Sandra, et al.
Publicado: (2021) -
A robust potency assay highlights significant donor variation of human mesenchymal stem/progenitor cell immune modulatory capacity and extended radio-resistance
por: Ketterl, Nina, et al.
Publicado: (2015) -
Human Platelet Lysate for Good Manufacturing Practice-Compliant Cell Production
por: Oeller, Michaela, et al.
Publicado: (2021)